Medical therapy vs surgery for recurrent acute rhinosinusitis

被引:25
|
作者
Costa, Milena L. [1 ,2 ]
Psaltis, Alkis J. [3 ]
Nayak, Jayakar V. [1 ]
Hwang, Peter H. [1 ]
机构
[1] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Stanford, CA 94305 USA
[2] Univ Sao Paulo, Sch Med, Clin Hosp, Dept Otolaryngol, Sao Paulo, Brazil
[3] Univ Adelaide, Dept Otolaryngol Head & Neck Surg, Adelaide, SA, Australia
关键词
recurrent acute rhinosinusitis; chronic rhinosinusitis; medical therapy; endoscopic sinus surgery; SNOT-22;
D O I
10.1002/alr.21533
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundTreatment indications for recurrent acute rhinosinusitis (RARS) remain poorly defined. We studied outcomes of medical vs surgical treatment of RARS, anatomic variants associated with RARS, and factors predicting crossover from medical to surgical treatment. MethodsA total of 220 RARS patients treated between 2006 and 2014 were retrospectively divided into 3 cohorts: medical only (MED); surgical only (SURG); or medical crossing over into surgical (CROSS). Twenty-two item Sino-Nasal Outcome Test (SNOT-22) scores, modified Lund-Kennedy endoscopy scores, and prevalence of anatomic variants by computed tomography (CT) were compared. A total of 220 CT scans obtained for non-sinus indications served as controls. A logistic regression model was used for analysis. ResultsThe mean baseline SNOT-22 scores for all cohorts were similar (MED = 48, SURG = 49, CROSS = 45, p < 0.0001). The SURG cohort showed greater reduction of SNOT-22 scores compared to the MED cohort at 3, 6, and 12 months follow-up (p < 0.0001). The crossover cohort converted to surgery after escalation of SNOT-22 score by a mean of 15 points (p < 0.03), and showed significant reduction postoperatively (p < 0.0001). Haller cell (odds ratio [OR] 3.9; p < 0.0001), concha bullosa (OR 3.7; p < 0.003), and accessory ostium (OR 2.2; p < 0.01) were more common in the entire RARS group vs controls; however, there were no inter-cohort differences in prevalence. ConclusionRARS patients can benefit from both medical and surgical treatment strategies, but surgical treatment results in greater symptomatic improvement compared to medical treatment. Patients cross over from medical to surgical treatment when SNOT-22 scores escalate by a mean of 15 points. Haller cell, concha bullosa, and accessory ostium are associated with RARS but are equally common in medical, surgical, and crossover cohorts.
引用
收藏
页码:667 / 673
页数:7
相关论文
共 50 条
  • [1] In reference to "Medical therapy vs surgery for recurrent acute rhinosinusitis"
    Bakshi, Satvinder Singh
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 (12) : 1185 - 1185
  • [2] Reply to: In reference to: Medical therapy vs surgery for recurrent acute rhinosinusitis
    Hwang, Peter H.
    Costa, Milena L.
    Psaltis, Alkis J.
    Nayak, Jayakar V.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 (12) : 1186 - 1186
  • [3] Is Sinus Surgery Indicated for Recurrent Acute Rhinosinusitis?
    Michalowski, Alexandra
    Kacker, Ashutosh
    LARYNGOSCOPE, 2017, 127 (06): : 1255 - 1256
  • [4] Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study
    Smith, Timothy L.
    Kern, Robert C.
    Palmer, James N.
    Schlosser, Rodney J.
    Chandra, Rakesh K.
    Chiu, Alexander G.
    Conley, David
    Mace, Jess C.
    Fu, Rongwei F.
    Stankiewicz, James A.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2011, 1 (04) : 235 - 241
  • [5] Recurrent acute rhinosinusitis: Presentation and outcomes of sinus surgery
    Poetker, David M.
    Litvack, Jamie R.
    Mace, Jess C.
    Smith, Timothy L.
    AMERICAN JOURNAL OF RHINOLOGY, 2008, 22 (03): : 329 - 333
  • [6] Medical therapy of acute and chronic frontal rhinosinusitis
    Maccabee, M
    Hwang, PH
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2001, 34 (01) : 41 - +
  • [7] Surgery Vs. Medical Treatment in Patients with Chronic Rhinosinusitis
    Philipp, Ami Thakor
    Yoo, Frederick
    Wang, Marilene
    Yusin, Joseph S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB69 - AB69
  • [8] Appropriateness Criteria for Surgery in the Management of Adult Recurrent Acute Rhinosinusitis
    Rudmik, Luke
    Beswick, Daniel M.
    Alt, Jeremiah A.
    Bhattacharyya, Neil
    Chester, Alexander C.
    Gray, Stacey T.
    Poetker, David M.
    Stewart, Michael G.
    Smith, Timothy L.
    LARYNGOSCOPE, 2019, 129 (01): : 37 - 44
  • [9] Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis
    Steele, Toby O.
    Detwiller, Kara Y.
    Mace, Jess C.
    Strong, E. Bradley
    Smith, Timothy L.
    Alt, Jeremiah A.
    LARYNGOSCOPE, 2016, 126 (05): : 1046 - 1053
  • [10] Microbiology of recurrent acute rhinosinusitis
    Brook, I
    Frazier, EH
    LARYNGOSCOPE, 2004, 114 (01): : 129 - 131